SCHEMBL26048626

SCHEMBL26048626

Bc1c(B)c(B)c(-c2c3ccccc3c(-c3cccc4oc5c(-c6ccccc6-c6ccccc6)cccc5c34)c3ccccc23)c(B)c1B

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKDC P78527 8/20 0.39
▸ ALOX5 P09917 2/20 0.35
▸ CDC14B O60729 1/20 0.33
▸ CDC14A Q9UNH5 1/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ PIK3CD O00329 3/20 0.33
▸ PIK3CA P42336 3/20 0.33
▸ PIK3CB P42338 3/20 0.33
▸ PIK3CG P48736 3/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ BRD4 O60885 2/20 0.33
▸ BRD2 P25440 2/20 0.33
▸ BRD3 Q15059 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ PDE2A O00408 1/20 0.33
▸ PIK3C2A O00443 1/20 0.33
▸ PIK3R2 O00459 1/20 0.33
▸ PIK3C2B O00750 1/20 0.33
▸ PDE5A O76074 1/20 0.33
▸ TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24178542 0.95 ALOX5 (0.39) PRKDCALOX5CDC14BCDC14AALDH1A1
SCHEMBL19770479 0.88 PRKDC (0.40) PRKDCALOX5CDC14BCDC14AALDH1A1
SCHEMBL26393024 0.87 PRKDC (0.41) PRKDCALOX5ALDH1A1PIK3CDPIK3CA
SCHEMBL25631816 0.87 ALOX5 (0.39) PRKDCALOX5CDC14BCDC14AALDH1A1
SCHEMBL22503842 0.86 ALOX5 (0.36) PRKDCALOX5CDC14BCDC14AALDH1A1
SCHEMBL25744446 0.86 ALOX5 (0.35) PRKDCALOX5AHR
SCHEMBL19784545 0.85 ALOX5 (0.36) PRKDCALOX5ALDH1A1PIK3CDPIK3CB
SCHEMBL19770492 0.85 ALOX5 (0.40) PRKDCALOX5CDC14BCDC14AALDH1A1
SCHEMBL22707249 0.84 ALOX5 (0.43) PRKDCALOX5CDC14BCDC14AALDH1A1
SCHEMBL21252608 0.82 CDC14B (0.46) PRKDCALOX5CDC14BCDC14AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230276706-A1 NOVEL HETEROCYCLIC COMPOUND AND LIGHT-EMITTING DIODE INCLUDING SAME SFC CO., LTD. (KR) 2023-08-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230276706-A1 NOVEL HETEROCYCLIC COMPOUND AND LIGHT-EMITTING DIODE INCLUDING SAME CYBA, CYP1B1, PPOX PRKDC 4328/4885ALOX5 454/4885CDC14B 3009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback